2008

RNA Technologies in Cardiovascular Medicine and Research

ISBN: 978-3-540-78708-2 (Print) 978-3-540-78709-9 (Online)

Table of contents (17 chapters)

  1. Front Matter

    Pages i-xiv

  2. MicroRNA

    1. No Access

      Book Chapter

      Pages 3-15

      An Overview of MicroRNA

    2. No Access

      Book Chapter

      Pages 17-34

      MicroRNAs and Their Potential

    3. No Access

      Book Chapter

      Pages 35-52

      miRNAs and Their Emerging Role in Cardiac Hypertrophy

    4. No Access

      Book Chapter

      Pages 53-68

      MicroRNAs and the Control of Heart Pathophysiology

    5. No Access

      Book Chapter

      Pages 69-86

      MicroRNA Systems Biology

  3. RNA Interference

    1. No Access

      Book Chapter

      Pages 89-107

      Targeting Viral Heart Disease by RNA Interference

    2. No Access

      Book Chapter

      Pages 109-130

      Design of siRNAs and shRNAs for RNA Interference: Possible Clinical Applications

    3. No Access

      Book Chapter

      Pages 131-166

      RNA Interference and MicroRNA Modulation for the Treatment of Cardiac Disorders

    4. No Access

      Book Chapter

      Pages 167-181

      Cardiac Delivery of Nucleic Acids by Transcriptional and Transductional Targeting of Adeno-Associated Viral Vectors

  4. Ribozymes

    1. No Access

      Book Chapter

      Pages 185-207

      Characterization of Hammerhead Ribozymes Potentially Suitable for the Treatment of Hyper-Proliferative Vascular Diseases

    2. No Access

      Book Chapter

      Pages 209-231

      Applications of Ribozymes and Pyrrole–Imidazole Polyamides for Cardiovascular and Renal Diseases

  5. Noncoding, Aptamer and Antisense RNAs

    1. No Access

      Book Chapter

      Pages 235-254

      Noncoding RNAs in Human Diseases

    2. No Access

      Book Chapter

      Pages 255-287

      Aptamers and siRNAs in Cardiovascular Disease

    3. No Access

      Book Chapter

      Pages 289-297

      Nucleic Acid Aptamers for Cardiovascular Therapeutics

    4. No Access

      Book Chapter

      Pages 299-309

      NFκB Decoy Oligodeoxynucleotide-Based Therapy in Cardiovascular Diseases

    5. No Access

      Book Chapter

      Pages 311-324

      Antisense Therapy for Restenosis Following Percutaneous Coronary Interventions

    6. No Access

      Book Chapter

      Pages 325-353

      Toxic RNA in Pathogenesis of Human Neuromuscular Disorders

  6. Back Matter

    Pages 355-358